ATE219665T1 - Dosisformen und deren verwendungen - Google Patents

Dosisformen und deren verwendungen

Info

Publication number
ATE219665T1
ATE219665T1 AT97907183T AT97907183T ATE219665T1 AT E219665 T1 ATE219665 T1 AT E219665T1 AT 97907183 T AT97907183 T AT 97907183T AT 97907183 T AT97907183 T AT 97907183T AT E219665 T1 ATE219665 T1 AT E219665T1
Authority
AT
Austria
Prior art keywords
dosage forms
verapamil
dosage form
single enantiomer
substantially single
Prior art date
Application number
AT97907183T
Other languages
English (en)
Inventor
Julian Clive Chiroscie Gilbert
Road
Andrew John Mcglashan Richards
Science Park Cambridge
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Application granted granted Critical
Publication of ATE219665T1 publication Critical patent/ATE219665T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97907183T 1996-03-11 1997-03-11 Dosisformen und deren verwendungen ATE219665T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9605074.5A GB9605074D0 (en) 1996-03-11 1996-03-11 Dosage forms and uses
PCT/GB1997/000674 WO1997033570A1 (en) 1996-03-11 1997-03-11 Dosage forms and uses

Publications (1)

Publication Number Publication Date
ATE219665T1 true ATE219665T1 (de) 2002-07-15

Family

ID=10790173

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97907183T ATE219665T1 (de) 1996-03-11 1997-03-11 Dosisformen und deren verwendungen

Country Status (10)

Country Link
US (1) US6267980B1 (de)
EP (1) EP0896530B1 (de)
JP (1) JP2000506856A (de)
AT (1) ATE219665T1 (de)
AU (1) AU1932997A (de)
DE (1) DE69713586T2 (de)
ES (1) ES2179302T3 (de)
GB (1) GB9605074D0 (de)
WO (1) WO1997033570A1 (de)
ZA (1) ZA972094B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044025A1 (en) * 1996-05-23 1997-11-27 G.D. Searle & Co. Pharmaceutical compositions containing non-racemic verapamil and process for optimizing the pharmaceutical activity of r- and s-verapamil
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
US20030092765A1 (en) 2001-11-15 2003-05-15 John Kelly Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil
WO2004093816A2 (en) * 2003-04-22 2004-11-04 Pharmacia Corporation Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent
US20050191245A1 (en) * 2004-02-27 2005-09-01 Adams Christopher P. Nasal administration of calcium channel, blockers for treatment of hypertension and other cardiovascular disorders
CA2659037A1 (en) * 2006-08-04 2008-03-13 Agi Therapeutics Research Limited Methods for treating at least one condition having mt1 receptor, 5ht2b receptor, and l-type calcium channel activity
EP3789022A1 (de) * 2012-12-27 2021-03-10 Massachusetts Eye & Ear Infirmary Behandlung von rhinosinusitis mit p-glycoprotein-hemmern
KR20240044546A (ko) * 2015-04-14 2024-04-04 마일스톤 파마슈티컬즈 인코포레이티드 단기 작용 페닐알킬아민 칼슘 채널 차단제의 고수용성 염 및 그 용도
US12295933B2 (en) 2019-03-25 2025-05-13 Massachusetts Eye And Ear Infirmary Methods and compositions to treat and diagnose diseases or pathologies associated with inflammation of the sinuses and nasal cavity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204116A (en) 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy
DE4319438C1 (de) * 1993-06-11 1994-06-01 Gerd Dr Dr Geislinger Arzneimittel auf der Grundlage von Ketoprofen zur Bekämpfung von Schmerzen und/oder Entzündungen und/oder Fieber an Menschen und Tieren

Also Published As

Publication number Publication date
US6267980B1 (en) 2001-07-31
EP0896530B1 (de) 2002-06-26
GB9605074D0 (en) 1996-05-08
DE69713586D1 (de) 2002-08-01
ZA972094B (en) 1998-03-11
JP2000506856A (ja) 2000-06-06
WO1997033570A1 (en) 1997-09-18
AU1932997A (en) 1997-10-01
EP0896530A1 (de) 1999-02-17
DE69713586T2 (de) 2003-01-09
ES2179302T3 (es) 2003-01-16

Similar Documents

Publication Publication Date Title
DK1036058T3 (da) Adamantanderivater
DK1036059T3 (da) Adamantanderivater
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
SE9704546D0 (sv) Novel compounds
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
LU91172I2 (fr) Melagatran, les stéréoisomères de celui-ci, et lessels physiologiquement acceptables de celui-ci (m elagatran astrazeneca).
ZA985364B (en) Pharmaceutical formulations containing voriconazole.
ZA9811504B (en) Novel pharmaceutical.
PT837684E (pt) Composicoes farmaceuticas a base de um sal de diclofenac e de tiocolchicosido
ATE219665T1 (de) Dosisformen und deren verwendungen
DK1044064T3 (da) Overtrækningsindretning til granula til indtagelse ad oral vej
ZA974270B (en) Pharmaceutical compositions based on diclofenac.
TR199501082A2 (tr) Farmasötik formülasyonlar.
AP2000001728A0 (en) Novel composition.
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
ZA988782B (en) Aporphinoid derivatives, processes for their production and pharmaceutical agents containing these compounds.
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.
MA26677A1 (fr) Medicaments antiparkinsoniens.
FI962120L (fi) Estramustiiniformulaatiot, joilla on parannetut farmaseuttiset ominaisuudet
RU96119163A (ru) Лекарственное антигипотензивное средство
RU95122486A (ru) Средство для лечения тикозных гиперкинезов
Yüceer Restoration project of Abacıoğlu Hanı in Kemeraltı, İzmir
IT233564Y1 (it) Macchina motocoltivatrice, particolarmente per prati e giardini.
ES1030947Y (es) Botellero apilable y desmontable, perfeccionado.
ZA9811472B (en) Novel amines as pharmaceutical agents.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties